Navigation Links
GlaxoSmithKline and Genmab Submit Arzerra(TM) (Ofatumumab) Application to FDA for the Treatment of Advanced Stage Blood Cancer
Date:1/30/2009

Three New Studies Initiated in Other Oncology Settings

LONDON and COPENHAGEN, Denmark, Jan. 30 /PRNewswire-USNewswire/ -- GlaxoSmithKline (GSK) and Genmab A/S (OMX: GEN) announced today the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for Arzerra(TM) (ofatumumab) to treat patients whose chronic lymphocytic leukemia (CLL) is resistant (refractory) to previous therapies. If approved, ofatumumab would be the first anti-CD20 monoclonal antibody available for this patient population.

CLL is the most common form of adult leukemia in the Western world,(1,2) affecting more than 90,000 Americans.(3) Patients with refractory CLL need new therapies since less than 25 percent respond to most current treatments while still having to cope with adverse effects.(4)

"The submission of the BLA for ofatumumab brings us closer to the possibility of providing a new treatment to patients with refractory CLL," said Lisa N. Drakeman, Ph.D., Chief Executive Officer of Genmab. "This is the first BLA ever filed for an antibody produced by Genmab and is a significant achievement in our partnership with GSK."

The submission is based on an analysis that included 138 patients with CLL who showed limited or no response to both fludarabine and alemtuzumab treatment (fludarabine alemtuzumab refractory) and patients who were refractory to fludarabine and considered inappropriate candidates for alemtuzumab due to bulky tumor masses (>5 cm) in their lymph nodes (bulky fludarabine refractory). The primary endpoint of the study was assessment of response. The overall response rate seen in these patient groups treated with single-agent ofatumumab was 58 percent for the fludarabine alemtuzumab refractory group (n=59) and 47 percent for the bulky fludarabine refractory group (n=79).(5,6)

The most common adverse events (AEs) seen with ofatumumab were re
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. GlaxoSmithKlines Drug Will Become New Clinical Gold Standard by 2012 for the Treatment of Relapsed/Refractory CLL
2. GlaxoSmithKline Awards Ten Area Healthcare Nonprofits with $40,000 Each in Funding
3. GlaxoSmithKline and Dynavax Announce Worldwide Strategic Alliance : – Developing First-in-Class Endosomal TLR Inhibitors for Autoimmune and Inflammatory Diseases –
4. GlaxoSmithKline Statement on FDA Advisory Committee Vote on Use of Asthma Medicines Containing Long-Acting Beta-Agonists
5. GlaxoSmithKline and The Carter Center Reaffirm Commitment to Global Public Health with Expansion of LF Program
6. GlaxoSmithKline to Acquire the Leading Dry Mouth Brand, Biotene
7. AUDIO from Medialink and GlaxoSmithKline: Give Kids A Boost For Their Health!
8. GlaxoSmithKline Acquires Sirtris Pharmaceuticals, Inc., a World Leader in Sirtuin Research and Development
9. Amira Pharmaceuticals Achieves Milestones in FLAP Inhibitor Program With GlaxoSmithKline
10. Emerging Combination Therapies, Including Drugs from Novartis/Schering-Plough and GlaxoSmithKline/Theravance Will Drive the COPD Drug Market to More Than $11 Billion in 2017
11. Video: GlaxoSmithKline Consumer Healthcare Offers Free Nicotine Lozenges for All Certified Pilots and Air Traffic Controllers to Help Them Safely Quit Smoking
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... 2015 Intermountain Healthcare of ... Stratus Video Interpreting for on-demand ... communication and timely care for patients with ... Stratus’ video remote interpreting (VRI) services will ... to quickly access qualified medical interpretation in ...
(Date:5/29/2015)... 2015 The print component of “Skin ... of approximately 250,000 and an estimated readership of 750,000. ... social media strategy, and across a network of top ... version of the campaign, click here. , ... Inside, the actress, model and producer details her skin ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 Mediaplanet has ... “beauty of protection”. Skin Health is a cross-platform ... within the markets of New York, Los Angeles, and ... 750,000 readers. Its digital counterpart will reach a national ... To read more the Skin Health campaign and Colorescience, ...
(Date:5/29/2015)... Chicago, Ill (PRWEB) May 29, 2015 ... Care , a dozen medical pioneers recognized by a ... changed the course of cancer treatment. Honorees will be ... of Cancer Care™ Award Ceremony, held 8:30-11:00 p.m. CDT ... , The 2015 honorees are being recognized for groundbreaking ...
(Date:5/29/2015)... Healthpointe is now offering pain ... therapy, and injections , For patients throughout Southern ... back pain, Healthpointe has a team of experts ... disc protrusions and other causes of back ... of renowned surgeons are now treating osteoarthritis, spinal ...
Breaking Medicine News(10 mins):Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 2Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 3Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 4Health News:Mediaplanet Launches “Skin Health” Campaign Featuring Colorescience 2Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 2Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 3Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 4Health News:Healthpointe’s Pain Management Specialists Now Providing Lumbar Epidural Injections in Los Angeles County 2Health News:Healthpointe’s Pain Management Specialists Now Providing Lumbar Epidural Injections in Los Angeles County 3
... The Financial Times has,selected the Campaign for ... its seasonal charity appeal to readers. CAMFED supports ... year,s appeal raised more over 600,000 pounds Sterling ... a series of articles from,November through to mid-January ...
... Materials for Medical Devices Database, CAMBRIDGE, England ... Design today announced substantial enhancement to,the only materials ... resource, demonstrated at this week,s Materials and Processes,for ... Desert, CA,now helps designers of spinal implants research ...
... Sept. 26 BioProcessors Corporation, a,leading innovator ... development, expands its Woburn operations and,launches new ... see strong interest in our SimCell technology," ... "The,biopharmaceutical industry is accelerating its pace to ...
... effort to ... health of Medicare beneficiaries, HANOVER, Md., Sept. 26 ... in partnership with,Medicare Part D prescription drug plans (PDPs) ... prescription drug therapy for Medicare,beneficiaries. Delmarva Foundation, Medicare,s QIO ...
... Sept. 26 October is Breast Cancer Awareness,Month, ... detection is at an,all-time high, the percentage of ... the Centers for Disease Control and,Prevention. Women should ... can do to maintain their long-term breast health. ...
... Sept. 26 Ziehm,Imaging, a provider of ... manufacturer of software-driven systems for targeted,less-invasive medical ... for the integration of mobile 3D C-arms ... Ziehm Imaging and BrainLAB jointly pioneered the ...
Cached Medicine News:Health News:Financial Times Selects CAMFED International for 2007 Reader Seasonal Appeal 2Health News:Financial Times Selects CAMFED International for 2007 Reader Seasonal Appeal 3Health News:Financial Times Selects CAMFED International for 2007 Reader Seasonal Appeal 4Health News:Financial Times Selects CAMFED International for 2007 Reader Seasonal Appeal 5Health News:Design Resource Extends Support for Orthopaedic and Cardiovascular Devices 2Health News:Design Resource Extends Support for Orthopaedic and Cardiovascular Devices 3Health News:BioProcessors Launches SimCell(TM) Services to Meet Increased Customer Demand 2Health News:Delmarva Foundation Implements Medication Therapy Management Program in Maryland and DC 2Health News:Revision: Ziehm Imaging and BrainLAB Announce Partnership for Intra-Operative 3D Imaging and Computer Assisted Surgery (CAS) 2Health News:Revision: Ziehm Imaging and BrainLAB Announce Partnership for Intra-Operative 3D Imaging and Computer Assisted Surgery (CAS) 3
(Date:5/29/2015)... Research and Markets ( http://www.researchandmarkets.com/research/p37spr/north_america ) has announced the ... Market - Growth, Trends And Forecasts (2014 - 2019)" ... players in the industry are GE , Hitachi Medical ... Systems MRI is a powerful ... higher sensitivity and use of non-ionizing radiations. Open MRI ...
(Date:5/29/2015)... , May 29, 2015  The annual customer satisfaction ... ranks Praxis EMR as #1 across all specialties. Every ... Research LLC conducts a poll of EHR users and ... results.    Praxis EMR topped 348 ... 18 performance based criteria used by Black Book. In ...
(Date:5/29/2015)... 29, 2015 Research and ... of the "Surgical/Operating Microscopes Market by Application ... report to their offering.      ... market is poised to reach $806.6 million by ... CAGR of 12.3% from 2015 to 2020. , ...
Breaking Medicine Technology:North America Open System MRI Market 2014-2019 with GE, Hitachi Medical, Philips Healthcare, Siemens Healthcare and Toshiba Medical Dominating 2Praxis EMR Ranks #1 for Physician Satisfaction in Black Book's 2015 Survey of Solo and Small Practices 2Surgical/Operating Microscopes Market by Application & End User - Global Forecast to 2020 for the $806 Million Industry 2
... The Procter & Gamble Company (NYSE: PG ) ... Sustainability Expert Advisory Panel (SEAP). The new members are: ... Global Initiative Dr. Howard Frumkin – Dean, School of ... Tamminen – Former Secretary, California Environmental Protection Agency ...
... HeartSine Technologies, Inc, a world leader in personal ... to an exclusive 10 years on its popular HeartSine ® ... (PAD) for the treatment of Sudden ... growing AED. The life of its Pad-Pak ® device, ...
Cached Medicine Technology:P&G Welcomes New Members to U.S. Sustainability Expert Advisory Panel 2P&G Welcomes New Members to U.S. Sustainability Expert Advisory Panel 3HeartSine® Increases AED System Warranty to Longest in the Industry 2
... oximeters available, Datex-Ohmeda s TuffSat is the ... transport, and EMS. TuffSat comes fully loaded ... index measurement) a quick, easy-to-use clinical ... perfusion at the sensor site. Now you ...
... clinical information. , ,S/5 Clinical Communications ... solutions that help you and your care ... You will have access to essential patient ... with your care team and specialists, independent ...
... safe and easy patient monitoring during MRI, ... special needs of the MRI environment. It allows ... MRI, promoting safety and flexibility., ,Though designed ... all the key benefits of the S/5 Monitoring ...
... and comprehensive solution for advanced arrhythmia ... (ARRWS) provides one compact, PC-based solution ... patients. It connects to Datex-Ohmeda Network ... up to 16 beds., ,The ...
Medicine Products: